Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XERECEPT for Peritumoral Brain Edema
NCT00088166Phase 3Completed
- Sponsor
- Celtic Pharma
- Start
- May 2004
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of corticotrophin-releasing hormone in Peritumoral brain edema (PTBE), sponsored by Celtic Pharma. Started May 2004; status: completed.
02
Drugs
corticotrophin-releasing hormone
03
Conditions
Peritumoral brain edema (PTBE)
Beyond the preview
Go deeper on NCT00088166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088166.